Published in Stroke on December 01, 1993
Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health (2010) 2.42
Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev (2010) 1.54
A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study. Am J Public Health (2000) 1.27
Acute cardioembolic cerebral infarction: answers to clinical questions. Curr Cardiol Rev (2012) 1.21
Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis. Osteoporos Int (2004) 0.86
Moderate alcohol intake reduces risk of ischemic stroke in Korea. Neurology (2015) 0.79
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology (2012) 2.86
Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis. Neurology (2011) 2.22
The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg (1989) 2.20
Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology (2011) 2.19
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol (2004) 2.12
Serial measurements of plasma homocysteine levels in early and late phases of ischemic stroke. Eur J Neurol (2007) 2.10
Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed) (1988) 1.90
Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub. Neurology (2011) 1.75
Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke (1999) 1.69
Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol (2001) 1.59
Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg (1997) 1.57
Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke (1997) 1.56
Neuropsychological sequelae of cardiac arrest. JAMA (1993) 1.52
Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology (2003) 1.47
Risk factors for cervical atherosclerosis in patients with transient ischemic attack or minor ischemic stroke. Stroke (1993) 1.42
Non-cholesterol sterols in serum and endarterectomized carotid arteries after a short-term plant stanol and sterol ester challenge. Nutr Metab Cardiovasc Dis (2010) 1.39
Ethanol intoxication: a risk factor for ischemic brain infarction in adolescents and young adults. Stroke (1982) 1.37
Clinical determinants of poststroke dementia. Stroke (1998) 1.36
Depression after stroke: results of the FINNSTROKE Study. Stroke (1998) 1.32
Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation (1996) 1.30
Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia (1999) 1.29
The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc Dis (1998) 1.29
Snoring as a risk factor for sleep-related brain infarction. Stroke (1989) 1.29
Diagnosis and management of brain death. Br Med J (1979) 1.28
Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke (2001) 1.27
White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry (2005) 1.24
Thromboembolism in patients with atrial fibrillation. Arch Neurol (1984) 1.22
Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci (2004) 1.21
Frequency and clinical determinants of poststroke depression. Stroke (1998) 1.20
Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proc Natl Acad Sci U S A (2000) 1.18
Is chronic brain damage in boxing a hazard of the past? Lancet (1982) 1.17
Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry (2006) 1.16
Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med (1989) 1.15
Cyclooxygenase-2 is induced globally in infarcted human brain. Ann Neurol (1998) 1.13
Recent alcohol consumption, cigarette smoking, and cerebral infarction in young adults. Stroke (1995) 1.12
Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol (1996) 1.11
Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts. Stroke (1996) 1.11
Brain creatine kinase in blood after acute brain injury. J Neurol Neurosurg Psychiatry (1975) 1.10
Post-stroke depression, executive dysfunction and functional outcome. Eur J Neurol (2002) 1.10
Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol (1989) 1.10
How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol (2000) 1.09
Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology (2006) 1.07
Insomnia in ischemic stroke patients. Cerebrovasc Dis (2002) 1.06
Outcome of 314 patients with transient ischemic attacks. Stroke (1982) 1.05
Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol (2003) 1.05
Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test. Eur J Clin Pharmacol (1981) 1.05
Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke. Stroke (1999) 1.01
Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry (2001) 0.99
Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry (1999) 0.99
The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. Stroke (2000) 0.99
Subarachnoid haemorrhage: long-term follow-up results of late surgical versus conservative treatment. Br Med J (1978) 0.98
Effects of ethanol on platelet function. Alcohol (1985) 0.97
MRI correlates of executive dysfunction in patients with ischaemic stroke. Eur J Neurol (2003) 0.97
Heart type creatine kinase isoenzyme (CK MB) in acute cerebral disorders. Br Heart J (1978) 0.96
Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol (1999) 0.96
Comparison of stroke features and disability in daily life in patients with ischemic stroke aged 55 to 70 and 71 to 85 years. Stroke (1997) 0.96
Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patients. Neurology (2011) 0.95
Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Stroke (1980) 0.95
Snoring, sleep apnea syndrome, and stroke. Neurology (1992) 0.94
Brain-type creatine kinase isoenzyme. Occurrence in serum in acute cerebral disorders. Arch Neurol (1977) 0.94
Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis. Neurology (2011) 0.94
Acute surgery for intracerebral haematomas caused by rupture of an intracranial arterial aneurysm. A prospective randomized study. Acta Neurochir (Wien) (1988) 0.93
Late prognosis of severe brain injury in children. Dev Med Child Neurol (1974) 0.93
Predicting late outcome for patients with traumatic brain injury referred to a rehabilitation programme: a study of 508 Finnish patients 5 years or more after injury. Brain Inj (1998) 0.93
Marchiafava-Bignami disease: two cases with favourable outcome. Eur J Neurol (2001) 0.93
Cognitive impairment predicts poststroke death in long-term follow-up. J Neurol Neurosurg Psychiatry (2009) 0.92
Ethanol intoxication: a risk factor for ischemic brain infarction. Stroke (1984) 0.91
Elevation of high-density lipoprotein in epileptic patients treated with phenytoin. Acta Med Scand (1978) 0.91
Age related white matter changes predict stroke death in long term follow-up. J Neurol Neurosurg Psychiatry (2009) 0.91
Cerebral convulsion after enfluran anaesthesia and occupational exposure to tetrahydrofuran. J Neurol Neurosurg Psychiatry (1984) 0.90
Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol (1999) 0.90
Does alcohol intoxication precipitate aneurysmal subarachnoid haemorrhage? J Neurol Neurosurg Psychiatry (1981) 0.90
Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial. JAMA (1990) 0.90
Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke. Neurology (2009) 0.89
Prognosis of patients with middle cerebral artery occlusion. Stroke (1976) 0.89
Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg (1991) 0.89
Increase of serum high-density lipoprotein in phenytoin users. Br Med J (1978) 0.89
Diagnosis and management of ischemic stroke. Part I.--Threatened stroke and its management. Curr Probl Cardiol (1983) 0.89
MRI correlates of dementia after first clinical ischemic stroke. J Neurol Sci (2000) 0.88
Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke (2000) 0.88
Suicidal ideas in stroke patients 3 and 15 months after stroke. Cerebrovasc Dis (2001) 0.88
Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost (1995) 0.88
Cognitive functions and depression as predictors of poor outcome 15 months after stroke. Cerebrovasc Dis (2002) 0.87
Alcohol abuse and brain infarction. Ann Med (1990) 0.87
Declining incidence and mortality rates of stroke in Finland from 1972 to 1991. Results of three population-based stroke registers. Stroke (1996) 0.87
Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand (2002) 0.86
European Stroke Initiative (EUSI) recommendations for stroke management. The European Stroke Initiative Writing Committee. Eur J Neurol (2000) 0.86
Poststroke depression in acute phase after stroke. Cerebrovasc Dis (2001) 0.85
Medial temporal lobe atrophy and memory deficits in elderly stroke patients. Eur J Neurol (2004) 0.85
Prognosis of patients with unilateral extracranial occlusion of the internal carotid artery. Stroke (1976) 0.85
Creatine kinase isoenzymes in acute brain injury. J Neurosurg (1981) 0.85
Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort. J Neurol Neurosurg Psychiatry (1999) 0.85